Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maverick BioMetals has developed proprietary synthetic enzyme and microbe-based technologies for extracting lithium, copper, rare earth elements, and other critical metals from hard rock ores. Their process operates at low temperatures with high recovery rates and produces no tailings or waste. The company is focused on sustainable mineral processing solutions that unlock previously unviable resources while reducing environmental impact. They have raised over $22 million in venture funding and are actively partnering with industry leaders to deploy their platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maverick BioMetals.